Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Weigh the advantages of ETF versus mutual fund for a Retirement SP 500 exposure, focusing on expenses, tax efficiency, and ease of rebalancing.
24,932 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
TIAA’s CEO argues that leaders should rent the title, not own it, and invest in character traits that endure beyond a...
A zeroed oracle signature unlocked a near $9 million loan from Bonzo Lend, triggering a protocol-wide pause and an in...
ON Semiconductor rides AI data-center demand and EV silicon trends to extend its rally, but analysts warn that valuat...
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A coalition of twelve states filed a federal antitrust suit to block Paramount's $81 billion merger with Warner Bros....
Cardano ADA surged after cooler US inflation data, with traders eyeing a potential breakout. On‑chain activity and wh...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
A major DeFi platform suffered a five-minute security incident on July 15, 2026, tied to forward-dated price feeds. E...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Lucid Group bucked volatility in the electric-vehicle space, rising for a third consecutive session and surpassing ke...
A bold forecast from Nvidia's founder centers on an AI spending boom. This article breaks down the rationale, the mat...